期刊文献+

HCCR-2基因沉默后HepG2肝癌细胞形态变化 被引量:1

The Morphology of HepG2 Liver Cancer Cells after Silencing HCCR-2 Gene
下载PDF
导出
摘要 目的研究HCCR-2基因表达沉默后肝癌细胞HepG2形态学的变化.方法将经测序证实的干扰质粒用脂质体法转染HepG2细胞,经G418持续压力选择和有限稀释法获得稳定转染的细胞系.分别用光镜、HE染色、荧光显微镜、透射电镜观察HepG2细胞转染前后形态学的改变.结果与亲本细胞相比,HCCR-2沉默后,HepG2细胞呈梭形,核浆比例有所下降,透射电镜下可观察到细胞核收缩变圆,胞质浓缩,细胞核中染色质边集、皱缩,密度增高.结论 RNAi介导的HCCR-2基因沉默可以促进HepG2细胞形态的改变及凋亡. Objective To investigate the morphological changes of HepG2 after silencing HCCR-2 by RNAi.Methods After confirmed by sequencing,the recombinant HCCR-2 RNAi vector was transfected into HepG2 cells by LipofectamineTM2000.Cells containing stable transformants were selected by the ability of resistance to G418 and isolated with a limited dilution.Morphological changes of the transfected cells were examined under light microscope,HE staining,inverted,fluorescence microscope and transmission electron microscope respectively.Results The transfected cells were transformed into fusiform and katyoplasmic ratio decreased to some extent.Cellular nucleus contracted and became round,cell kytoplasm condensed in the transfected cells.Chromatin margination and crimple were also observed under transmission electron in the transfected cells.Conclusion RNAi eukaryotic expression vector targeting HCCR-2 can promote the morphological changes and apoptosis of HepG2 cells
出处 《昆明医学院学报》 2010年第10期27-30,共4页 Journal of Kunming Medical College
关键词 人子宫癌基因-2 RNA干扰 肝癌 HCCR-2 RNA interference Liver cancer
  • 相关文献

参考文献2

二级参考文献26

  • 1郭军,房殿春,姜锋,杨仕明.人子宫颈癌基因HCCR-2真核表达载体的构建及鉴定[J].第四军医大学学报,2007,28(3):250-252. 被引量:1
  • 2杨杨,张国新,施瑞华,林艳,郝波,王晓勇,王宏娣,黄祖瑚.人宫颈癌基因蛋白在人肝细胞癌中的表达及其临床意义[J].中华肝脏病杂志,2007,15(3):223-224. 被引量:21
  • 3Ko J, Lee YH, Hwang SY, et al. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene, 2003 ,22:4679-4689.
  • 4Chung YJ, Kim JW. Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer. Histol Histopathol, 2005,20: 999-1003.
  • 5Ko J, Shin SM, Oh YM, et al. Transgenic mouse model for breast cancer:induction of breast cancer in novel oncogene HCCR-2 transgenic mice. Oncogene, 2004,23 : 1950-1953.
  • 6Cho GW, Shin SM, Kim HK, et al. HCCR-1, a novel oncogene, encodes a mitochondrlal outer membrane protein and suppresses the UVC induced apoptosis. BMC Cell Biol, 2007,8:50.
  • 7Shin SM, Chung YJ, Oh ST, et al. HCCR-1-interacting molecule "deleted in polyposis l" plays a tumor suppressor role in colon carcinogenesis. Gastroenterology, 2006 , 130:2074-2086.
  • 8Yoon SK, Lim NK, Ha SA, et al. The human cervical cancer oncogene protein is a hiomarker for human hepatocellular carcinoma. Cancer Res,2004 ,64:5434-5441.
  • 9Jung SS, Park HS, Lee IJ, et al. The HCCR oncoprotein as a biomarker for human breast cancer. Clin Cancer Res, 2005, 11: 7700- 7708.
  • 10Orlacchio A, Bernardi G, Orlacchio A, et al. RNA interference as a tool for Alzheimer's disease therapy. Mini Rev Med Chem, 2007 , 7:1166- 1176.

共引文献4

同被引文献3

引证文献1

  • 1李鹏姗,雷雪芹,徐廷生,王攀林,宋祯,李振红,史明艳,韦光辉,张广平,李俊堂.转人抑癌基因p53鸡的研究[J].西北农林科技大学学报(自然科学版),2019,0(7):54-61.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部